Skip to search.
 STI Down1.77%

Ariad Pharmaceuticals Inc. (ARIA)

-NasdaqGS

19.57 Up 0.13(0.67%) 25 May 04:00 SGT|After Hours : 19.50 Down 0.07 (0.36%) 25 May 07:23 SGT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2012Dec 31, 2011Dec 31, 2010
Total Revenue 558   25,300   178,980  
Cost of Revenue -   -   -  
Gross Profit 558   25,300   178,980  
Operating Expenses
Research Development144,709  77,743  57,985  
Selling General and Administrative60,909  24,380  16,095  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (205,060) (76,823) 104,900  
Income from Continuing Operations
Total Other Income/Expenses Net(15,613)(46,548)(19,446)
Earnings Before Interest And Taxes(220,673)(123,371)85,454  
Interest Expense199  232  206  
Income Before Tax(220,872)(123,603)85,248  
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(220,872)(123,603)85,248  
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (220,872) (123,603) 85,248  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (220,872) (123,603) 85,248  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.